Spire Healthcare Group (SPI) Share Price, News & Analysis

Company Overview

Spire Healthcare Group plc, together with its subsidiaries, owns and operates private hospitals and clinics. It offers various treatments in the areas of allergy and infectious diseases, blood tests, bones and joints, bowel treatments, breast screening and surgery, cancer investigations and treatments, cosmetic surgery, cyst removal, and dental surgery, as well as ear, nose, and throat treatments. The company also provides eye surgery and treatments, family planning, gastroenterology, general medicine, general surgery, haematology, hand surgery, hip and knee treatment, and heart and kidney treatments. In addition, it offers treatments in the areas of men's health, neurosurgery and neurology, paediatrics, pain management, rehabilitation, sports, physiotherapy, podiatry, respiratory medicine, and rheumatology; and scans and investigations, skin treatments, spinal care, sports science, urology, vascular surgery, weight loss, and women's health. Further, the company offers various tests and scans, which include cardiac CT, CT, MRI, ultrasound, and X-ray scans. It offers in-patient, daycase, and out-patient care services through hospitals and clinics across England, Wales, and Scotland. Spire Healthcare Group plc was founded in 2007 and is headquartered in London, the United Kingdom.

Key Stats

• Today's Range: 224 to 228.50
• 50-Day Range: 223 to 237
• 52-Week Range: 212.50 to 270.50
• Volume: 168,221 shs
• Average Volume: 598,162 shs
• Market Capitalization: £917.59 million
• P/E Ratio: 32.52
• Dividend Yield: 1.31%
• Price Target: GBX 322
• Consensus Rating: Buy

Spire Healthcare Group Stock Analysis - MarketRank™

Spire Healthcare Group scored higher than 34% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.5 / 5
• Analyst Rating: Buy

Consensus Rating

Spire Healthcare Group has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

Amount of Analyst Coverage

Spire Healthcare Group has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.0 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Spire Healthcare Group is 32.52, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 21.37.

Price to Earnings Ratio vs. Sector

The P/E ratio of Spire Healthcare Group is 32.52, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 16.51.

Price to Earnings Growth Ratio

Spire Healthcare Group has a PEG Ratio of 1.06. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Spire Healthcare Group has a P/B Ratio of 1.25. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for SPI.

Dividend

• Score: 0.8 / 5
• Dividend Strength: Weak

Dividend Yield

Spire Healthcare Group has a dividend yield of 0.01%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

Spire Healthcare Group does not have a long track record of dividend growth.

Dividend Coverage

The dividend payout ratio of Spire Healthcare Group is 42.70%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: N/A
• Environmental Score: N/A

Short Interest

There is no current short interest data available for SPI.

News and Social Media

• Score: 0.0 / 5
• News Sentiment: N/A

News Coverage This Week

MarketBeat has tracked 1 news article for Spire Healthcare Group this week, compared to 2 articles on an average week.

Search Interest

Only 4 people have searched for SPI on MarketBeat in the last 30 days. This is a decrease of -43% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Spire Healthcare Group insiders have not sold or bought any company stock.

Percentage Held by Insiders

34.71% of the stock of Spire Healthcare Group is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

50.37% of the stock of Spire Healthcare Group is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

SPI Stock Analysis - Frequently Asked Questions

How have SPI shares performed this year?

Spire Healthcare Group's stock was trading at GBX 226 at the beginning of the year. Since then, SPI stock has increased by 1.1% and is now trading at GBX 228.50.
View the best growth stocks for 2025 here.

How were Spire Healthcare Group's earnings last quarter?

Spire Healthcare Group plc (LON:SPI) issued its quarterly earnings results on Friday, March, 2nd. The company reported $14.40 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $14.60 by $0.20. The firm earned $931.70 million during the quarter. Spire Healthcare Group had a trailing twelve-month return on equity of 3.82% and a net margin of 1.96%.

How do I buy shares of Spire Healthcare Group?

Shares of SPI stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

What other stocks do shareholders of Spire Healthcare Group own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Spire Healthcare Group investors own include Tenet Healthcare (THC), Mediclinic International (MDC), Barclays (BARC), Johnson Matthey (JMAT), Kindred Biosciences (KIN), Peloton Interactive (PTON) and BAE Systems (BA).

Company Calendar

• Last Earnings: 3/02/2018
• Today: 2/22/2025

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Medical Care Facilities
• Sub-Industry: Electronic Equipment
• Current Symbol: LON:SPI
• CUSIP: N/A
• CIK: N/A
• Web: investors.spirehealthcare.com
• Phone: 44 20 7427 9000
• Fax: N/A
• Employees: 420
• Year Founded: N/A

Price Target and Rating

• Average Stock Price Target: GBX 322
• High Stock Price Target: GBX 344
• Low Stock Price Target: GBX 300
• Potential Upside/Downside: +40.9%
• Consensus Rating: Buy
• Rating Score (0-4): 3.00
• Research Coverage: 2 Analysts

Profitability

• EPS (Most Recent Fiscal Year): GBX 7.03
• Trailing P/E Ratio: 32.52
• Forward P/E Ratio: 14.59
• P/E Growth: 1.06
• Net Income: £28.15 million
• Net Margins: 1.96%
• Pretax Margin: N/A
• Return on Equity: 3.82%
• Return on Assets: 3.73%

Debt

• Debt-to-Equity Ratio: 62.25
• Current Ratio: 0.70
• Quick Ratio: 0.74

Sales & Book Value

• Annual Sales: £1.44 billion
• Price / Sales: 0.64
• Cash Flow: GBX 25.05 per share
• Price / Cash Flow: 9.12
• Book Value: GBX 183 per share
• Price / Book: 1.25

Miscellaneous

• Outstanding Shares: 401,569,133
• Free Float: N/A
• Market Cap: £917.59 million
• Optionable: Not Optionable
• Beta: 0.96